VCI Global Limited unveiled a strategic collaboration with Evolve Capital Advisory Private Limited. This collaboration seeks to cultivate a comprehensive avenue, providing companies with enhanced opportunities to facilitate capital markets access through public listings on NASDAQ or SGX. Evolve Capital, a boutique investment bank focusing on growth enterprises across Southeast Asia, brings extensive expertise in providing comprehensive strategic advice, including M&A and capital markets capabilities.

As a holder of the Capital Market Services Licence authorized by the Monetary Authority of Singapore (?MAS?), Evolve Capital is also an Accredited Mainboard Issue Manager and Catalist Full Sponsor by the Singapore Exchange Limited. Additionally, Evolve Capital has achieved the distinction of being the first Asia-based firm granted the OTCQX and OTCQB Sponsor license by OTC Markets Group Inc., offering alternative listing options for in the United States. While acknowledging the unique strengths of various international exchanges, this collaboration seeks to provide companies with an optimal pathway to listing, including NASDAQ as a strategic option.

The U.S. capital markets, renowned for their size, liquidity, and stability, offer an additional avenue for global issuers to access capital. The synergistic strengths of VCI Global and Evolve Capital aim to establish a versatile platform that caters to the evolving needs of businesses in today?s dynamic market environment. This endeavour is further fortified by VCI Global?s extensive consultancy experience, having played a pivotal role for numerous companies, especially in tandem with their listing endeavours on NASDAQ.